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Abstract        
The biological clock regulates a myriad of physiological functions. It is synchronized by 
various environmental cues and follows a 24-hour cycle with variable start and end points 
that are referred to as “chronotypes”. The suprachiasmatic nucleus (SCN) in the brain 
orchestrates the circadian rhythm as the central clock of the body, with oscillating expression 
of biological clock genes, including the PERIOD genes. The biological rhythm is modulated 
by serotonergic neurotransmission, with the largest afferent projection to the SCN coming 
from the serotonergic median raphe nucleus. Also, disruptions of the biological rhythm 
contribute to the pathophysiology of various psychiatric disorders. For instance, in clinical 
depression (a hypo-serotonergic state), patients exhibit a generalized disruption of their 
biological rhythm in the form of disturbances in sleep, hormonal, mood and temperature 
rhythms. 
The main aim of our study is to investigate the intercorrelations between four factors: 
genotype, depression symptoms, chronotype and brain functionality.  We examined the 
interaction between serotonin neurotransmission, electroencephalography (EEG) brain 
oscillations, chronotype, and the expression of depression symptomatology in healthy 
subjects. In particular, we examined naturally-occurring genetic polymorphisms in the 5-
HT1A receptor gene and the PER2 clock gene as indirect measures of serotonergic 
neurotransmission and the circadian clock, respectively. 
We recruited Sixty-three healthy subjects who underwent evaluations for biological clock 
phase (chronotype), clinical depression symptomatology. A subgroup of the subjects 
underwent EEG testing to measure their baseline brain activity and response to various 
stimuli. A proportion of the subjects were genotyped for 5-HT1A receptor (28 subjects) and 
the PER2 polymorphisms (41 subjects). 
iii 
 
Our results confirmed the interaction between the four studied factors. We found that 
subjects with the later chronotype express higher level of depression symptoms. The power of 
brain’s theta oscillation was positively correlated with chronotype. We found that females 
had an earlier chronotype than males, which can be explained by the differences we found in 
their genotypes. This can be considered an indirect evidence for the correlation between 
genotype and chronotype, but a direct link that confirms these results is still lacking.  
This study provides preliminary evidence for the molecular underpinnings of the 
interaction of biological clock functioning with serotonin as a potential mechanism for the 
development of clinical depression. Future studies should include a larger sample size and 
patients with clinical depression to clearly find the differences between healthy and clinical 
states in terms of chronotypes, genotypes and brain funcionality. This will help build a 
comprehensive overview of the underlying pathophysiology of clinical depression. 
Ultimately, this can inform the development of novel treatment modalities that take into 
account not just the symptomatology of clinical depression, but also genetic, physiological, 
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Chronotype: The individual variations in the biological clock, it appears as a 
personal preference of sleep and wake timing, activity timing, meal timing … 
etc. Some people tend to be later chronotypes, who sleep later and wake up 
later, become more active at a later-than-average time. Some are early people, 
who tend to wake up earlier, sleep earlier and become more active at an earlier 
time. 
Zeitgebers: German for “Time givers”, are the environmental cues that drive 
our biological clock, such as sunlight, which is the main zeitgeber. It also 
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1. Chapter One: 
ــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــ 
 Introduction and Literature Review 
1.1 Molecular Underpinnings of the Biological Clock 
There are multiple physiological processes in the body that follow a circadian rhythm, 
meaning that they follow an endogenously-controlled regular rhythm that repeats every 24 
hours. These include sleep-wake cycle, temperature control, fat and glucose metabolism, 
among others (Cardinali & Pandi-Perumal, 2011). These biological processes are governed 
by three main clocks. These are the biological clock, the social clock and the solar clock. 
The biological clock is the one endogenous to the body. It is a clock that can run free from 
outside environmental factors, and we feel it mostly when we experience jet lag or change 
work shifts. The social clock is defined by regular social events, such as work times, sleep 
times, and other social habits. The solar clock is the main clock that follows a 24-hour 
rhythm in accordance with the 24-hour cycle of the day. It is controlled by light and is the 
main clock that entrains (synchronizes) the other two clocks with it. In real life, these three 
clocks are usually in synchrony (Roenneberg, Kumar, & Merrow, 2007; Roenneberg, 
Wirz-Justice, & Merrow, 2003). 
People can be divided in terms of their circadian rhythm variability into different 
chronotypes. A Chronotype is defined as the personal preference in terms of the daily 
rhythm of sleep, wake and activities, with earlier chronotypes having earlier rhythms, and 
later chronotypes having later rhythms (Nováková, Sládek, & Sumová, 2013; Roenneberg 
et al., 2003). These different chronotypes have basis in the genetic expression level, with 
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circadian clock genes varying in expression according to each person’s chronotype 
(Nováková et al., 2013). 
Zeitgebers (German for “time-givers”) are daily environmental or external signals that 
entrain the biological clock and thus the entire circadian rhythm (Grandin, Alloy, & 
Abramson, 2006; Roenneberg & Merrow, 2016). The most prominent zeitgeber is light 
which affects the solar clock, which in turn affects the biological clock. The biological 
clock functions to entrain all peripheral clocks in the body using “internal zeitgebers”, 
which are basically hormonal or neuronal inputs to peripheral organs (Curtis, Bellet, 
Sassone-Corsi, & O’Neill, 2014; Germain & Kupfer, 2008; Roenneberg et al., 2007). 
External zeitgebers include specific behavioral factors as well, such as sleep time, nicotine 
and alcohol consumption, sleep deprivation … etc, which might affect the biological clock 
directly or indirectly (Roenneberg & Merrow, 2016). 
The main circadian pacemaker in mammals is found in the suprachiasmatic nucleus 
(SCN) in the anterior hypothalamus. It contains an autonomous clock that maintains 
rhythmicity, and can be considered as an entrainable oscillator that functions even before 
birth (Weaver, 1998). Although this structure was recognized anatomically, it wasn’t until 
the 1970s that its function as a temporal regulator was recognized (Moore, Speh, & Leak, 
2002). 
There are three major inputs to the SCN. The first is the retinohypothalamic tract, which 
originates from retinal ganglion cells, and sends photic (light) signals by releasing 
glutamate in the SCN. The other input is from the median raphe nucleus, which release 
serotonin at target neurons in the SCN. A third input comes from the intergeniculate 
leaflet, which is controlled by the dorsal raphe nucleus. It conveys its signals to the SCN 
through the release of neuropeptide Y. The two main pathways from the retina and the 
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median raphe inhibit the function of each other, and both of them terminate in the middle 
of SCN (Ciarleglio, Resuehr, & McMahon, 2011; Germain & Kupfer, 2008). 
Major output targets of SCN include the paraventricular nucleus of the hypothalamus, 
which affects melatonin secretion, pituitary hormones and the sympathetic and 
parasympathetic nervous systems. The dorsomedial hypothalamic nucleus is another major 
output target. It affects the circadian rhythm of cortisol and other hormones, and sleep. 
SCN then synchronizes peripheral tissues by both hormonal and neuronal signals. Cells of 
particular organs such as the kidneys and liver, can synchronize with SCN through the 
hormonal signal only, while others, such as the heart and skeletal muscles, require 
neuronal input (Germain & Kupfer, 2008). 
Cells of the SCN as well as the peripheral tissues, follow a common mechanism of 
achieving circadian rhythmicity of gene expression (Fig. 1.1). The biological clock at the 
molecular level includes genes that are controlled by proteins that are able to inhibit their 
own function in rhythmic manner. The activation of the biological clock genes is initiated 
by two transcription factors of the helix-loop-helix PAS-domain containing family of 
transcription factors. They control transcription of other genes, including the PER1,2 and 
3, and CRY1 and 2 genes. The products of these genes form PER-CRY dimers and 
translocate back from the cytoplasm to the nucleus to inhibit Bmal1 and Clock gene 
expression. The main controller for the rhythmicity of the biological clock is the delayed 
translation/transcription feedback loop, that is controlled by phosphorylation of clock 
proteins by casien kinase epsilon and delta (CKIε/δ) (Cardinali & Pandi-Perumal, 2011; 
Dibner, Schibler, & Albrecht, 2010). 
The suggested mechanism of PER2- and CRY1 in inhibiting the actions of BMAL1 
involves two steps. The first step occurs at the beginning of the circadian cycle (at dawn), 
where CRY1 binds to BMAL-CLOCK-E-Box complex and inhibits transcription by 
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blocking it. At night, both PER2 and CRY1 cause dissociation of CLOCK-BMAL1 from 
the promoter, causing transcription repression (Ye et al., 2014). 
PER2 contains a coding-region polymorphism, the rs934945. This polymorphism 
results in G to A substitution (Englund et al., 2009; Lee et al., 2011). Diurnal preference 
was found to be associated with this polymorphism, with the G-variant being associated 
with morningness phenotype in specific (Lee et al., 2011; Song et al., 2016) The authors of 
(Lee et al., 2011) suggest that this might indicate that G-variant genotype results in a less 
functional variant of PER2, thus leading to more morningness. However, other studies 
failed to show an effect of this polymorphism on morningness (Carpen, Archer, Skene, 





 Figure  1.1: Simplified schematic diagram showing the cycle of mammalian clock 
genes. BMAL1 and CLOCK form a heterodimer that binds to the EBox elements of target 
clock genes, including PER1, 2 and 3, and CRY1 and 2, activating their transcription. The 
resulting proteins in the cytoplasm multimerize, enter the nucleus and inhibit the action of 
BMAL1 and CLOCK. ZT: Zeitgeber time, which represents time in a 12:12 light-dark 




 1.2 Molecular Biology of Clinical Depression 
 Tryptophan is an essential amino acid that plays a major role in the brain-immune-
endocrine systems interaction. It is metabolized in the liver, the periphery (macrophages) 
and the central nervous system. There are two main pathways for Tryptophan, the 
kynurenine and serotonin pathways (Fig. 1.2). The Kynurenine pathway is the dominant 
pathway, and 99% of tryptophan is metabolized in the pathway. It involves the opening of 
the indole ring of tryptophan through the action of one of two enzymes, the 2,3-dioxy-
genase, which is found only in the liver, and the indoleamine 2,3-dioxygenase, which is 
found in the periphery and the central nervous system. One of the products of the 
kynurenine pathway is 3-hydroxykynurenine which is known to be harmful for neurons, as 
it causes neuronal death from free radicals (de Jong, Smit, Bakker, de Vries, & Kema, 
2009; Miura et al., 2008). 
 The other pathway is the production of serotonin from tryptophan. After tryptophan 
enters the brain through a carrier, it is converted to 5-HTP (5-Hydroxytryptophan) by the 
action of tryptophan hydroxylase, and is then converted to serotonin (5-HT; 5-
Hydroxytryptamine). When a serotonergic neuron in the brain releases serotonin in the 
synaptic terminal, serotonin needs to be retaken to the same terminal again, and is either 
metabolized to 5-HIAA (5-Hydroxyindoleacetic acid) or repackaged in vesicles for further 





Figure 1.2: Pathways of tryptophan in producing serotonin or kynurenine. Less 
production of serotonin in favor of kynurenine might be harmful for neurons. The 
kynurenine pathway metabolizes 99% of dietry intake of tryptophan, and the serotonin 
pathway metabolizes 
  
It has been postulated that serotonin levels in the brain directly control the expression of 
depression symptomatology. This is known as the monoamine hypothesis of clinical 
depression. It states that the low levels of monoamines, serotonin and norepinephrine, is 
related to the onset and symptoms of clinical depression (Miura et al., 2008). This 
hypothesis is one of the most well-established theories of clinical depression (Hindmarch, 
2001). There are findings supporting the monoamine hypothesis of clinical depression, and 
these include the relapse of depressive symptoms after tryptophan depletion or inhibition 
of tryptophan hydroxylase, mood lowering after tryptophan depletion in recovered patients 
and vulnerable healthy controls, decreased sensitivity in 5-HT1A receptors and 5-HT1B 
receptor malfunctioning (Belmaker & Agam, 2008; Miura et al., 2008). 
Serotonin is released mainly from the raphe nucleus in the brain stem. It sends 
serotonergic input to various areas in the brain (Savitz, Lucki, & Drevets, 2009). There are 
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14 subtypes of serotonin neurotransmitters that belong to 7 main families (Blier & Abbott, 
2001). Polymorphic changes in these receptors’ genes can affect some psychiatric 
illnesses. For example, a polymorphism affecting the 5-HT2A receptor is correlated with 
clinical depression and response to treatment, and 5-HT3 is correlated with schizophrenia 
and bipolar disorder (Savitz et al., 2009). 
5-HT1A receptor is the best characterized of these receptors, it is found both 
postsynaptically in neurons of target areas, or presynaptically. The presynaptic 5-HT1A is 
an autoreceptor that, when activated, reduces the firing rate, firing amount and 
neurotransmitter synthesis in the presynaptic neuron. Thus, it has the ability to modulate 
serotonergic function in the brain, such as cognition and emotion. Furthermore, it can 
affect neuronal migration, axonal and dendritic outgrowth and synapse formation. This 
makes the 5HT1A receptor a good candidate to play a role in affective disorders (Albert & 
Lemonde, 2004; Savitz et al., 2009). 
5-HT1A is associated with clinical depression. It is hypothesized that there are 
alterations (increase) in basal expression of 5-HT1A autoreceptors in clinical depression. 
In general, there are multiple mechanisms that reduce 5-HT transmission can predispose to 
clinical depression (Albert & Lemonde, 2004). On the other hand, there are different lines 
of evidence suggesting that antidepressants exert their effects through this receptor. 
Selective serotonin reuptake inhibitors (SSRIs) and monoamine oxidase inhibitors cause 
desensitization of presynaptic 5-HT1A, while tricyclic antidepressants increase 
sensitization of postsynaptic 5-HT1A (Savitz et al., 2009). 
5-HT1A receptor promoter contains a functional polymorphism under the name C(-
1019)G (rs6295). The G variant was found to increase autoreceptor activity in raphe 
neurons, which causes these neurons to become less active in terms of serotonin firing rate 
and amplitude, which in turn increases the risk for developing clinical depression. It was 
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also found to decrease resilience to stressful events (Benedetti et al., 2011). Patients with 
clinical depression were found to have the G/G variant of the polymorphism twice as much 
as the non-depressed. This variant was also associated with suicide, with 4 fold increase in 
those who committed suicide (Lemonde et al., 2003). However, there are studies done on 
healthy controls that did not support this, in which there was no difference in serotonin 
binding in either genotype of 5HT1A receptor, which suggests that it expresses its effect in 
the disease state only (David  et al., 2011). The suggested underlying mechanism involves 
the nuclear-deformed epidermal autoregulatory factor (DEAF)-1-related protein (NUDR). 
NUDR is a transcription repressor that can bind the C variant of the polymorphism and not 
the G variant. This means that NUDR only represses the activity of the C variant, which 
decreases autoreceptors activity in this variant. This is not the case in G variant, and this 
increases the activity of autoreceptors in this variant more, increasing the risk of clinical 
depression (Lemonde et al., 2003; Watanabe et al., 2017). 
1.3 Clinical Depression and the Disruption of the Biological Clock 
 One of the most prominent features of clinical depression is the disruption of the 
circadian clock in the form of sleep disturbances. It can manifest in the form of inability to 
initiate sleep, inability to maintain sleep, early morning waking, excessive sleepiness … 
etc. This has been reported in 70-80% of patients with clinical depression (American 
Psychiatric Association, 2013; Bunney & Potkin, 2008). Other abnormalities include 
hormonal dysregulation of melatonin and cortisol. Disruption of the diurnal regulation of 
temperature, which appears as an increase in core body temperature at night, has been 
reported. Finally, many patients with clinical depression report having melancholic mood 




 Symptoms of clinical depression might be related to chronotype. In patients with 
clinical depression, eveningness is associated with more suicidal thoughts, work 
impairment and anxiety symptoms (Gaspar-Barba et al., 2009). This correlation has also 
been reported in healthy subjects, in which healthy controls with later chronotype were 
found to show more severe depression symptoms (Hidalgo et al., 2009; Levandovski et al., 
2011). 
 Clock genes can affect mood-related behaviors. For example, patients with clinical 
depression showed lower CRY2 baseline levels, and no upregulation of CRY2 expression 
following sleep deprivation (Lavebratt et al., 2010). In another study, chronic 
unpredictable stress was shown to have depressive properties. It showed that the oscillation 
of PER2 expression in specific, and not PER1, was reduced in the SCN. This effect of 
chronic stress in reducing PER2 oscillation was removed after the introduction of 
desipramine, an antidepressant (Jiang et al., 2011). These results suggest that biological 
clock changes are present on the molecular level in patients with clinical depression. 
 1.4 Interplay Between Serotonin and the Circadian Clock 
 There are three main inputs to the SCN. The first is the retinohypothalamic tract, 
which relays light signals to the SCN. The second input is from the median raphe nucleus, 
which affects the SCN by releasing serotonin at the target cells. The  third pathway starts 
from the dorsal raphe nucleus, which sends serotonergic signals to the IGL, which in turn 
affects the SCN through the release of neuropeptide Y (Ciarleglio et al., 2011; Germain & 
Kupfer, 2008). 
 Serotonin is a main neurotransmitter that plays a role in non-photic entrainment of 
the circadian clock. Serotonergic agonists can cause phase advance in the circadian 
rhythm, and this is suggested to be through the reduction of both PER1 and PER2 mRNA 
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levels (K Horikawa et al., 2000). Activation of 5-HT1A and 5HT7 receptors mediate non-
photic signals to the SCN. This happens through both receptors functioning in synchrony 
and not separately (Kazumasa Horikawa, Fuji, Fukazawa, & Shibata, 2013). 
 A suggested correlation between PER2 and monoamines comes from the theory of 
Hampp & Albrecht (2008). This theory is based on findings in mammals, and it states that 
phosphorylation of PER2 by GSK-3β increases PER2 accumulation in the nucleus, which 
enhances transcription of monoamine oxidase A (MAO-A) by NPAS/BMAL1. MAO-A 
degrades dopamine and serotonin (Owens & Nemeroff, 1994). This indicates that higher 
PER2 levels increase serotonin degradation, increasing the chance of depression. 
  
  
Figure 1.3: Graphical representation of the input pathways to the SCN. The main input 
is from light, transmitted to the SCN through the retinohypothalamic tract. The MRN gives 
direct serotonergic input to the SCN. DRN sends serotonergic projection to IGL, which in 
turn controls the SCN through neuropeptide Y. 
DRN = Dorsal Raphe Nucleus, IGL = Intergeniculate Leaflet, MRN = Median Raphe 
Nucleus, RHT = Retinohypothalamic Tract and SCN = Suprachiasmatic Nucleus.  
The figure used the following figures from the web: (“File:Brain bulbar region.svg - 
Wikimedia Commons,” n.d.; “The Sun 4 Free Stock Photo - Public Domain Pictures,”). 
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 1.5 Electroencephalography, Clinical Depression and the Circadian 
Clock 
1.5.1 EEG and Clinical Depression: 
Studying brain oscillations can provide us with valuable information about the correlation 
between clinical depression,sleep patterns, and other neurophysiological signals that can be 
collected via EEG. It has been reported that EEG pattern during sleep is different in 
patients with clinical depression than healthy controls. These differences include reduced 
sleep efficiency, reduced power of the entire oscillation spectrum, especially the delta 
waves, reduced rapid eye movement (REM) latency and changes in REM density (Kupfer 
et al., 1980; Mendelson et al., 1987). 
Previous studies introduced valuable information about mood and how it correlates with 
brain oscillations. The brain's asymmetric activity was correlated to response to positive 
and negative stimuli, with higher left brain activation being associated with more positive 
mood in response to positive stimuli. Conversely,activation of the right brain was 
associated with more negative responsiveness to negative stimuli (Kupfer, Spiker, Coble, 
& Neil, 1998).  These findings were replicated in patients with clinical depression, where 
Henriques and Davidson found that there was less activation of the left side of the brain, as 
evident from the higher alpha activity in that side (Henriques & Davidson, 1991). 
These findings, including changes in brain function and laterality in alpha activity, 
might be challenged by the fact that such changes do not regress after treatment of clinical 
depression (Fingelkurts et al., 2006). However, this doesn’t change the fact that clinical 
depression is associated with changes in brain physiology. These changes might be evident 
in these patients, regardless of the expression of symptoms. Furthermore, it was reported 
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that patients with clinical depression have higher alpha and beta, and lower delta power. 
EEG power changes in patients with clinical depression were found to happen across 
nearly the whole cortex and it showed changes in frequency composition over a wide range 
of frequencies (Fingelkurts et al., 2006). 
1.5.2 EEG and the Circadian Clock 
EEG can be used to identify and analyse various stages of sleep (Hori et al., 2001; 
Rechtschaffen & Kales, 1968). Advancements in EEG computation helpeded in studying 
contributions of various frequency components to sleepiness and wakefulness (De 
Gennaro, Ferrara, & Bertini, 2001) 
EEG spectral analysis in various studies found that alpha power decreases during 
wakefulness while theta power increases. These power changes can be used as an indicator 
of sleepiness, and might be a representation of the homeostatic process (Arcady A Putilov, 
Donskaya, & Verevkin, 2012), which is the process in which the drive for sleep increases 
during wakefulness (Borbély & Achermann, 1999). The same study also suggests that the 
theta to alpha power change ratio is a better predictor than any of them alone. 
Chronotype naturally affects sleepiness and wakefulness patterns. EEG studies 
performed during wakefulness show that chronotype can affect EEG signal of wakefulness 
and sleepiness (A A Putilov, Donskaya, & Verevkin, 2009). An EEG sleep study done on 
morning- and evening-types of people found that REM latency was the only variable 
different between morning people and evening people, which they attributed to other 




 1.6 Problem Statement: 
 The effects of biological clock variations on clinical depression are well 
established. However, the interaction between the genotype, brain oscillations, chronotype, 
and clinical depression symptomatology levels  warrants further investigation in a more 
coherent way. This can be done by assembling a theoretical framework for the relationship 
between these different factors to evaluate the interaction between all of these  levels to 
shed light on the pathophysiology of clinical depression. 
 1.7 Study Justification 
Since the effects of genotypes in general are complex and likely multidimensional, 
studying multiple aspects of genotype effects will give a more comprehensive overview of 
the effects of genotype. This study will allow us to search for the interaction effect between 
the four factors of study, which will lead us to formulate a comprehensive overview on 
how these factors participate in producing clinical depression. 
1.8 Study Goals 
To examine the gene-oscillation-chronotype-symptom axis by examining the interaction 
between serotonin and the circadian clock at the genetic level to infer effects on brain 
oscillations, chronotypes, and depression symptomatology. 
1.9 Significance of the Study 
- Mapping the neural basis of circadian rhythms as well as the effect of selected genes 
onto the symptoms of clinical depression. 
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-  Inform the design of future treatment modalities for clinical depression that capitalize 
on circadian rhythms. 
1.10 Study Questions 
- Is there an effect of 5-HT1A and PER2 genotypes on brain oscillations,chronotype, 
and depression symptom severity? 
- Is there a correlation between chronotype and the severity of depression symptoms? 
- Is there an interaction between chronotype and the severity of depression symptoms 
with brain oscillations? 
1.11 Predictions 
We predict that the G variant of 5-HT1A polymorphism (rs6295) is associated with 
eveningness. This is based on the finding that the G variant is associated with less 
serotonin activity (Benedetti et al., 2011), and the notion that higher serotonin leads to 
phase advance (K Horikawa et al., 2000), which means that lower serotonin (G variant) 
will lead to phase delay, and thus more eveningness. For PER2, we expect that the G-
variant is associated with morningness, which is what was found in (Lee et al., 2011). 
We predict that the G-variant of 5-HT1A and the A-variant of PER2 are associated with 
less serotonin levels and later chronotype, and that the C-variant of 5-HT1A and the G-
variant of PER2 are associated with higher serotonin and earlier chronotype. The high-




Depression scores are predicted to change according to 5-HT1A polymorphism. The G-
variant is expected to give more tendency towards depression, as it is associated with lower 
serotonin levels (Benedetti et al., 2011). 
We predict that later chronotype is associated with more depression. This is based on 
the findings of (Hidalgo et al., 2009; Levandovski et al., 2011) 
We also predict a negative association between chronotype and theta power in EEG. 
The hypothesis is based on findings reported by Putilov and colleagues  (Arcady A Putilov 
et al., 2012). The authors found that theta power increases during wakefulness. This 
indicates that the more the wakefulness period, the more the theta power. Since earlier 
chronotype have larger wakefulness period at any particular point in the day, earlier 
chronotype is expected to be associated with more theta power. 
Finally, I predict to have higher theta power in subjects with more morningness-
genotype (the G variant in PER2, and the C variant in 5-HT1A).  
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2. Chapter Two:  
ـــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــ  
Materials and Methods 
2.1 Subjects 
Sixty-three subjects were randomly recruited from Al-Quds university students and the 
general population in the West Bank, Palestine. Demographic data are presented in (Table 
2.1). All subjects underwent the mini international neuropsychiatric interview (Amorim, 
Lecrubier, Weiller, Hergueta, & Sheehan, 1998). All subjects were psychologically healthy 
at the time of testing according to the MINI. Five subjects had a history of clinical 
depression previously. 
 
Table 2.1: Demographic data for the participants 
Demographic Value 
Age (Mean ± SD)  20.93 ± 2.07 years 
Gender (Female %) 63.2 % 
Education (Mean ± SD) 14.61 ± 2 years 
  
2.2 Ethical considerations 
 This research was conducted based on the Declaration of Helsinki and was 
approved by the Al-Quds University Research Ethics Committee. A clear description of 
the procedure was given to subjects prior to testing. A written informed consent was 
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obtained from all subjects prior to starting the testing protocol. The signed consent forms 
are available upon request. 
2.3 Psychometric and Chronotype Questionnaires 
2.3.1 The Beck Depression Inventory II (BDI-II) 
 The BDI-II (Beck, Steer, & Brown, 1996) is a 21-item questionnaire that assesses 
cognitive, affective and somatic symptoms of depression. Each question has choices that 
range from 0 (no symptoms) to 3 (severe symptoms), with a final score between 0-63 
(Levandovski et al., 2011). 
2.3.2 The Munich ChronoType Questionnaire (MCTQ) 
 The MCTQ (Roenneberg et al., 2003) is a questionnaire that assesses personal 
chronotype in a quantitative manner. It does so by asking about personal preferences of 
sleeping and waking during free and work days. Chronotype is calculated based on mid-
sleep time in free days. Mid-sleep time is expected to change because of the sleep debt the 
subjects accumulate during the week. That is why, chronotype is calculated based on a 
corrected mid-sleep time that takes into account this sleep debt (Allebrandt & Roenneberg, 
2008). 
2.4 Blood Collection and DNA Extraction: 
About 5 ml of blood were drawn from each subject. The samples were centrifuged at 
1000g for 10 minutes. The buffy coat was then taken and DNA was extracted using 
MasterPure DNA Purification Kit for Blood Version II ©. 
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 2.5 Primer Design 
 Primers were designed using Prime 3.0 software for both 5-HT1A receptor and 
PER2 polymorphisms. 
The first primer was for 5-HT1A receptor polymorphism (rs6295). The primers are 
displayed in (Table 2.2). For the 5-HT1A receptor polymorphism, there was no enzyme 
that can cut at the site of polymorphism. The reverse primer was designed so that it 
overlaps the polymorphism site, and we introduced a mismatch at the nucleotide second to 
last in the reverse primer, thereby creating an artificial polymorphic restriction site that can 
be cut using the HpyCH4IV restriction enzyme (Beste, Heil, Domschke, & Konrad, 2010; 
Hong, Chen, Yu, & Tsai, 2006). 
The second primer was for the PER2 polymorphism. The primers are shown in (Table 
2.2), and the cutting enzyme was BamHI. 
 
Table  2.2: Primers used, their sequences, and their cuttings enzymes 















 2.6 Polymerase Chain Reaction (PCR): 
 We used Syntezza tubes (Syntezza Bioscience Ltd., Jerusalem, Israel) for preparing 
the PCR mix. The mix for both polymorphisms was similar in proportions. For each 
sample, the mix consisted of 18 µl of ultrapure water, 0.5 µl of the forward primer (which 
is equivalent to one unit), 0.5 µl of the reverse primer (which is equivalent to one unit) and 
1.5 µl of DNA, with a final volume of 20.5 µl. 
Twenty-eight subjects had their PCR done for 5-HT1AR polymorphism. The PCR 
protocol followed for 5-HT1AR polymorphism consisted of an initial denaturation at 95 °C 
for 3 minutes, followed by 35 cycles of 95 °C for 30 seconds, 58 °C for 30 seconds and 72 
for 30 seconds. This was followed by 7 minutes of 72 °C (Fig. 2.1 - right). 
Forty-one subjects had their PCR done for PER2 polymorphism. The PCR protocol for 
the PER2 consisted of an initial denaturation at 95 °C for 2 minutes, followed by 35 cycles 
of 95 °C for 30 seconds, 58 °C for 30 seconds and 72 for 45 seconds. This was followed by 
5 minutes of final elongation at 72 °C (Fig. 2.1 - left). 
 2.7 Restriction Fragment Length Polymorphism (RFLP) Analysis 
 The Nebcutter tool (“NEBcutter V2.0 | LabTools,” n.d.). For 5-HT1A, the 
enzyme HpyCH4IV was used, which cuts at the palindromic sequence A˅CGT. The length 
of PCR product is 182 nucleotides. For the genotype that has the C variant, the enzyme 
will cut and produce two bands with lengths of 157 and 25. For the G-variant, the enzyme 
will not cut, and the product will be of length 182 (Fig. 2.2 - left). 
The enzyme digestion mix consisted of 13 µl ultrapure water, 0.1 µl of the cutting 
enzyme, 2 µl of the buffer and 5-7 µl of the pcr product. The incubation period for the 
enzyme digestion mix was 30-60 minutes at 37 °C. 
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For PER2, the enzyme BamHI was used, which cuts at the sequence G˅GATCC. The 
length of PCR product is 163 nucleotides. For the genotype that has the G variant, the 
enzyme will cut and produce two bands with lengths of 121 and 42. For the A-variant, the 
enzyme does not cut, and the product is of length 163 (Fig. 2.2 - right). 
The enzyme digestion mix consisted of 13 µl ultrapure water, 0.1 µl of the cutting 
enzyme, 2 µl of the buffer and 5 µl of the pcr product. The incubation period for the 
enzyme digestion mix was 60 minutes at 37 °C. 
 2.8 Measure of DNA Concentration and Purity 
 DNA concentrations were measured using a NanoDrop Spectrophotometer. 10 
Samples were chosen to check DNA concentration and A260/A280. Mean concentration 
was 629.46 ± 464.27 ng/µL, and values ranged from 28 - 1560). 
A260/A280 is a measure of DNA purity, it may indicate the presence of a protein, 
phenol or other contaminants in the sample. A measure of more than 1.80 is considered an 
acceptable number for DNA. For our samples, mean A260/A280 was 1.913 and SD was 




 Figure 2.1: Gel electrophoresis of PCR product for PER2 (left) and 5-HT1A (right). 






Figure 2.2: Enzyme digestion product for PER2 (left) and 5-HT1A (right). Products of 
enzyme digestion for the G-variant of PER2 are 121+42, and for 5-HT1A the digestion 




 2.9 Electroencephalography (EEG) 
 A subset of our subjects underwent EEG recording in Al-Quds university. 
Electrical signals of the brain were acquired on scalp using a 23-channel recording system 
(Virgo 32, Allengers Global Healthcare Pvt. Ltd.). EEG was recorded according to the 
international 10/20 system. A recording cap was used for the recording consisting of 21 
electrodes. Two additional electrodes were added manually on the frontal (FPz) and 
occipital (Oz) areas. Eye blinks and horizontal eye movements were recorded in synchrony 
using two electrodes attached above and below the right and left eye, respectively.  
Data analysis, including noise and artifact rejection, were done using the MNE-Python 
toolbox (Gramfort et al., 2014). All data were bandpass filtered between 1-40 Hz. 
Artifacts were removed using independent component analysis (ICA). After segmenting 
the data into 5-minutes segments, ICA was applied to each segment separately. An 
automatic identification scheme was applied to search for ocular activity using either both 
ocular or two frontal channels (FP1 and FP2). The identification of cardiac activity was 
done by visual inspection.  In some segments an additional artifact was identified that 
resulted from the stimulus computer that is used to play the task. This artifact was also 
removed by means of the corresponding components Finally, bad segments of the data 
(i.e., EEG signals exceeding untypical large magnitudes) were identified and annotated by 
using a threshold of 270 µV. These data segments were discarded from analysis. 
EEG resting state recordings ranging from 5-20 minutes were recorded with eyes open 
(Mean ± SD =  10.7 ± 5.8) and 5-20 minutes with the eyes closed (Mean ± SD= 15.5 ± 
5.55) in a comfortable sitting position in a quiet room. For the eyes open study, the 
subjects were asked to fixate on a crosshair placed in the middle of a white A4 paper with 
50 cm distance in order to limit horizontal eye movement. For the eyes closed study, the 
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subjects were asked to close their eyes for 20 minutes and try not to sleep. the tester 
monitored the subjects to make sure they do not fall asleep during the session. 
The subjects were then asked to play a probabilistic feedback-based learning and 
categorization task (Bódi et al., 2009). This task includes two types of stimuli, the 
rewarding stimuli and the punishing stimuli. The rewarding stimuli give either reward 
(smiling face) or no feedback when the subject answers correctly or incorrectly, 
respectively. The punishing stimuli give either no feedback or a punishing feedback (sad 
face) when the subject answers correctly or incorrectly, respectively. The computer screen 
was placed about 50 cm in front of the subject in a comfortable sitting position. The task 
consisted of 280 trials, divided between rewarding stimuli and punishing stimuli. The 
stimulus is presented to the subject and the task waits for the response of the subject. After 
the subject responds to the stimulus, the answer is presented for 1 second, then a cross sign 
is presented for a variable time between 0.74 and 0.84 seconds, then the feedback is 
presented for a variable time between 0.72 - 0.82 seconds. 
2.10 Statistical Analysis 
2.10.1 Inferential Statistics: 
We used R programming language version 3.5.2 and SPSS V20 to conduct the analyses. 
In order to test the interaction between genotypes in affecting depression symptoms and 
chronotypes, we divided the subjects according to their genotypes to two groups per 
genotype. For PER2, subjects who were homozygous for the G-allele were put in the group 
“G-Homo”, the rest were named “A-Carrier”. For 5-HT1A, subjects homozygous for the 
G-allele were named “G-Homo”, the rest were put under the name “C-Carrier”. These 
groups were entered as two independent variables in two-way MANOVA., with 
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chronotype and BDI-II scores as the dependent variables. Gender was included in this 
ANOVA, to see the effect of gender on the chronotype. 
Finally, The correlation between chronotype and depression was tested using two 
methods. The first is a t-test between BDI-II score of early chronotypes, and BDI-II score 
of later chronotypes. Then a correlational analysis was conducted between mid-sleep time 
in free days, as an additional measure of chronotype, and BDI-II scores. 
2.10.2 EEG Analysis 
In this part of the analysis, we tested a subgroup of our sample using EEG, as an additional 
way of looking at brain functionality and connecting it with the underlying aspects of the 
biological clock, genotype and depression symptomatology. 
As a first step in this analysis, we identified the most prominent channel that reflects 
most of the signal changes during the task. For this, we need to measure brain activity after 
giving stimuli that are known to activate the brain at specific time points. 
To do that, we introduced a feedback-based learning task to look at brain activation at 
specific time periods. The task asks the subject to categorize objects into two groups of 
categories, and based on that it gives a reward or a punishment. The content of the task and 
the results obtained from it are not relevant to our study. We will use the task only for 
analyzing the brain's response to reward and punishment. 
To identify the most relevant electrode position for our study, a Monte Carlo cluster 
permutation test was applied based on the method introduced by (Maris & Oostenveld, 
2007) and implemented in MNE-Python (Gramfort et al., 2014) using EEG signals from all 
subjects averaged upon stimulus onset. For testing variations within the spatio-temporal 
dynamics, t-scores were computed over a time window ranging from 0 to 600 ms 
following stimulus onset, using a large amount of permutations (104). To identify a 
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significant increase in the EEG signal changes a critical alpha level of 0.05 was used. As 
the cluster level permutation test addresses the multiple comparison problem at the same 
time (Maris & Oostenveld, 2007), the increased signal changes reflect a significance level 
of p≤0.05. 
The second step was to compare brain alpha and theta waves in different groups of 
subjects. First, chronotype correlation with brain waves was calculated. Second, alpha and 
theta waves were correlated with BDI-II using the same test. 
The effects of genotypes on alpha and theta content was also tested using independent 
samples t-test. The number of subjects did not allow us to perform more complicated tests 








The results of genotyping are provided in (Table 3.1). Hardy-Weinberg equilibrium was 
done using chi-square-test revealed a non-significant deviation from the Hardy-Weinberg 
equilibrium for both genotypes (5-HT1A: 𝜒2 = 0.03541, p-value = 1, PER2: 𝜒2 = 0.17778, 
p-value = 1). Linkage disequilibrium analysis revealed no linkage disequilibrium between 
the two genotypes (D’ = 0.1771, 𝑟2 = 0.02, 𝜒2= 1.099, p = 0.294), See (Table 3.1) for 
details. 
Differences between males and females in terms of genotype distribution showed a 
significant effect of gender in the PER2 gene but not in 5-HT1A. Female:Male ratio in the 






Table 3.1: 5-HT1A and PER2 haplotypes. Shown are the frequencies for 5-HT1A and 
PER2. D’ and p-value for linkage disequilibrium analysis are also shown. 
               5HT1AR 
PER2 
GG GC CC D’ p 
GG 7 6 1 0.1771 0.294 
GA 3 6 2 










Genotype Female Male Total 𝜒𝟐 P value 
5-HT1A 
C/C 1 2 3 0.41 0.815 
G/C 7 6 13 
G/G 6 6 12 
PER2 
A/A 0 2 2 8.152 0.017 
G/A 6 9 15 





3.2 Effect of Genotype on Chronotype and BDI-II 
The effect of 5-HT1A and PER2 groups on depression symptoms and chronotype was 
tested using MANOVA. Results show the absence of significant difference for both 5-
HT1A and PER2, with no interaction between them. The effect for gender was significant 
in this ANOVA. See (Table 3.3) and (Figure 3.1) for MANOVA details. 
Following on this with between-subjects tests, The effect of gender was shown to be 
affecting the chronotype (F-value = 14.258, p=0.004). With the chronotype of females 
(mean =4.2, SD =1.62) than the chronotype of males (mean = 5.68, SD = 0.96). 
 
 
Table 3.3: MANOVA results for the effect of genotypes and gender or depression 
symptoms and chronotypes. Significant effects are marked with a star. 
Variable (s) F df between df within P value 
5-HT1A 0.455 2 8 0.650 
PER2 0.586 2 8 0.579 
Gender 6.686 2 8 0.020* 
5-HT1A*PER2 0.190 2 8 0.830 
5-HT1A*Gender 0.311 2 8 0.741 
PER2*Gender 0.084 2 8 0.921 




 Figure 3.1: General look at the interaction effects of 5-HT1A and PER2 as the 
independent variables, on chronotype and BDI-II as the dependent variables, with. There 




 3.3 Comparing Chronotype and BDI-II 
Next, I looked at the effect of chronotype on BDI-II. The mean BDI-II value for early 
chronotype subjects (mean =8.4, SD = 4.2) was not significantly different than the mean 
BDI-II value for subjects with late chronotype (mean = 11.2, SD = 7.5). T-test shows a 
non-significant effect (t(29.31) = 1.387, p-value = 0.176). See (Figure 3.2) for details. 
This test was followed by a correlation test between mid-sleep time in free days, as a 
simple measure of chronotype (Figure 3.3). Pearson’s correlation analysis showed that 
there was a significant correlation between BDI-II and mid-sleep in free days (r = 0.428, n 
= 45, p = 0.003). A partial correlation followed this test, we tested the correlation between 
BDI-II and mid-sleep time taking into account the weekly sleep loss. The partial 
correlation was also significant (r=0.402, n=45, p = 0.007). This indicates that mid-sleep 
time was significantly correlated with BDI-II symptoms even when taking the weekly 






Figure 3.2: Comparing BDI scores according to chronotype. Later chronotype did not 




Figure 3.3: The correlation between midsleep time and depression scores as measured 





 3.4 EEG Data Analysis 
 3.4.1 Identifying the most relevant electrode position 
The first step in this EEG analysis was to determine the electrode that reflects most of 
the signal changes due to probabilistic learning. This was done using a spatio-temporal 
cluster permutation test. To find the most prominent cluster that picked up most of the 
brain signal, we looked at brain signals after giving feedback to the subjects. We used three 
comparisons: Reward Vs no feedback, Punishment VS no feedback and reward VS 
punishment. In all three comparisons the area at the middle of the brain was activated the 
most. This includes electrode Cz, which is the electrode located in the center of the cluster 
with the largest magnitude. Hence, the electrode Cz was used for subsequent analysis. See 





Figure 3.4: Three feedback comparisons were done to identify the most prominent 
channel. The first is punishment signal VS no feedback signal, the second is the reward 
signal VS no feedback signal, and the third is the reward signal VS the punishment signal. 





3.4.2 EEG Findings 
Theta wave power was calculated for the channel Cz as the most prominent channel. 
The interaction between theta and chronotype was calculated. A significant interaction was 
found between the two factors. Pearson’s correlation (r(5)=0.9, p = 0.006) showed there is 
a significant interaction effect with large size. (Figure 3.5) gives more details. 
Finally, testing the differences in theta power in terms of the expected serotonin content 
(based on genotype) showed that subject group with higher expected serotonin (Mean = 
3253, SD = 3298) did not differ significantly from the group of lower expected serotonin 
(Mean = 3954, SD = 2954). T-test result showed the absence of significant effect (t(5) = 













4.1 Findings Summary 
There was neither an effect of the 5-HT1A or PER2 genotypes nor an interaction 
between the genotypes on depression symptoms and chronotype. There was a significant 
effect for gender on chronotype, with females having earlier chronotypes. Depression 
symptoms did not correlate with chronotype, but it correlated significantly with mid-sleep 
time (another measure of chronotype). Theta activity in EEG was significantly correlated 
with chronotype. 
4.2 Chronotype, Depression Symptoms and Genotype 
We based our genotype prediction of serotonin levels on previous findings. (Benedetti et 
al., 2011) found that the G-variant of 5-HT1A is associated with more autoreceptor 
activity, which leads to less serotonin activity indicating that the C variant is associated 
with more serotonin activity. As for (Lee et al., 2011), they suggest that the G-variant of 
PER2 polymorphism leads to less functional protein and more morningness. We combined 
this with the suggested hypothesis of Hampp & Albrecht (2008), which states that lower 
PER2 levels decrease serotonin breakdown. This indicates that the G-variant of PER2 is 
associated with higher levels of serotonin. We searched for these expected differences 
between genotypes in terms of chronotype and depression symptoms.  
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We divided the subjects in terms of their 5-HT1A receptor genotype into G-
Homozygous and C-Carriers, and according to PER2 into G-Homozygous and A-Carriers. 
We expected to find an interaction between the two genotypes in which the C-Carriers of 
5-HTA1 and the G-Homozygous of PER2 will be associated with higher serotonin levels, 
and thus more morningness and lower depression symptoms. We did not find an effect of 
either of the genotype nor there was an interaction between them. 
The interactions between the genotype-predicted serotonin level and the chronotype- 
and BDI-II-predicted serotonin levels were explored. No effect of genotype-predicted 
serotonin level on chronotype of BDI-II scores was observed. Notably in our sample, we 
only included 11 subjects who had their chronotype, BDI-II, 5-HT1A genotype and PER2 
genotype completed. Such a low number is hard to be used to find group differences that 
are as subtle as the effects of serotonin changes. However, we found find an indirect 
correlation between the genotype and phenotype. Females had higher G/G frequency as 
compared to males. The female subjects also had earlier chronotypes.  
 4.3 Chronotype and Depression Symptomatology  
 Previous studies show that later chronotypes are associated with higher severity of 
depressive symptoms (Hidalgo et al., 2009; Levandovski et al., 2011). In the present study, 
a similar effect for later chronotypes could not be detected in our subjects. The calculation 
of chronotype was originally based on mid-sleep time (Roenneberg et al., 2003), and was 
modified later to take the weekly sleep debt into account. The currently used method in 
calculating chronotype according to Roenneberg et al. (2004) involves calculating sleep 
duration difference between free days and the average weekly sleep duration, then 
subtracting half of this amount from the mid-sleep time in free days. While this method 
takes into account the sleep debt accumulating during work days, it does that with no 
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regard to the amount of sleep loss itself. Rather, it uses an indicator of sleep loss. In our 
case, we proposed a new method of calculating the effects of chronotype that takes sleep 
loss directly into account. We used the mid-sleep time as the chronotype, but when 
performing correlations, we took the calculated weekly sleep loss into account. However, it 
might not be usable to compare chronotype as a solid number in other tests, such as the 
ANOVA. 
  We did a partial correlation between mid-sleep time and BDI-II, taking into 
account sleep loss. The results showed that mid-sleep time is positively correlated with 
depression symptoms. This falls in line with findings in previous studies (Gaspar-Barba et 
al., 2009; Hidalgo et al., 2009; Levandovski et al., 2011). 
4.4 Brain Oscillations and Chronotype 
The first step was to determine the channel that picks up the most of neural processing 
involved in picking up the rewarding and punishing feedbacks. To do this, we introduced a 
probabilistic feedback-based learning task for the mere purpose of measuring brain signal 
in response to reward and punishment stimuli. For identification of the most relevant 
electrode we analyzed three types of brain response signals (brain signal in response to 
reward, punishment, and no-feedback) using a spatio-temporal cluster permutation test. We 
found that the channel Cz picked most of the activity involved in processing probabilistic 
learning. This channel was used for further analysis. 
Theta activity is considered as a measure of wakefulness and an indicator of the 
homeostatic process (Arcady A Putilov et al., 2012; Strijkstra, Beersma, Drayer, 
Halbesma, & Daan, 2003) that builds up during the day. Earlier chronotypes are expected 
to have higher sleepiness scores since they have had been awake for a longer time period at 
the time of testing session, and thus they are expected to have a higher theta activity. This 
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was not the case in our sample. In fact, we found a strong positive correlation between 
chronotype and theta power, with later chronotypes having stronger theta power. This can 
be explained by that subjects with later chronotypes have more sleepiness during working 
days as a result of having less sleep time, as indicated by later biological clock. 
Accordingly, the main factor here is sleepiness that results from sleep loss, and not from 
the longer awake time. 
4.5 Limitations 
The major limitation was the small sample size in terms of genotyping. Only 28 subjects 
undergone 5-HT1A genotyping and 41 for PER2. Our study measured the interaction 
between many factors, and this requires a larger sample size in general given the subtle 
changes, such as the interplay of serotonin and behavior, that we are investigating. 
In addition, the confined range of depression symptoms given the recruitment of healthy 
subjects was another limiting step. Including patients with clinical depression will provide 
a new aspect to our study. 
4.6 Conclusions 
The results of this study provide further evidence about the correlation between 
genotype and phenotype in terms of molecular correlates, brain oscillations, chronotype, 
and clinical depression. Females had a higher frequency of the G allele in both 5-HT1AR 
and PER2 alongside early chronotype. There was a positive interaction between 
chronotype and clinical depression, with later chronotypes having higher severity of 
depression symptoms, especially when using a chronotype calculation that takes sleep loss 
into account. Chronotype was also associated with a change in brain oscillations in terms 
of higher theta waves for later chronotypes. Based on our findings, serotonin and clock 
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genes could play a role in controlling chronotype, thus affecting brain oscillations and 
depression symptomatology. However, a direct connection between them is still lacking. 
This research provides the basis for further experiments in the future. More subjects will be 
included in our study, and more polymorphisms will be examined in clock and serotonin 
genes. This will go hand in hand with analysis of brain oscillations in EEG that provides 
valuable a physiological measure of brain function.  
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وتواسطھا في التفاعل بین الاكتئاب لساعة البیولوجیة التفاعل بین جینات السیروتونین وا
 السریري والأنماط الزمنیة
 إعداد: عبد الرحمن صلاح جبر سوالمة
 المشرف الأول: د. محمد مصطفى حرز الله
 المشرف المشارك: د. یورغن دامرز
 
 الملخص
العدید من الإشارات البیئیة تعمل تتحكم الساعة البیولوجیة بعدد كبیر من الوظائف الفیزیولوجیة، و
ساعة تتباین في نقطة بدایتھا ونقطة  42تتبع دورة مدتھا على مزامنة ھذه الساعة، بحیث المحیطة 
( NCSھو ما یشار إلیھ "بالنمط الزمني". تتحكم النواة فوق التصالبة )واختصاًرا ھذا التباین نھایتھا، و
المركزیة للجسم، وما یتبعھا من تذبذب في التعبیر  الساعةَ في الدماغ بالنظم الیوماوي، وتشكل بذلك 
. كما یتأثر النظم الحیوي بالنقل DOIREPعن جینات الساعة البیولوجیة، والتي تشتمل على جینات 
تأتي من النواة الرفائیة الإنسیة التي  NCSالعصبي السیروتونیني. بل إن المسارات الواردة إلى الـ
الاختلالات التي تحدث في النظم البیولوجي في تساھم اقل عصبي. وتستخدم السیروتونین كن
فعلى سبیل المثال، یعاني مرضى الاكتئاب  ؛رابات النفسیةطضلعدید من الاباالفیزیولوجیا المرضیة 
كحالة نقص في السیروتونین( من خلل عام في النظم البیولوجي لدیھم على شكل  )والذي یمكن اعتباره
 النوم والھرمونات ودرجات الحرارة.نظم اختلالات في 
الھدف الرئیس لدراستنا ھو إیجاد العلاقة التبادلیة بین أربعة عوامل؛ وھي النمط الجیني، وأعراض 
بحثنا في ھذه الدراسة في العلاقة المتبادلة بین النقل الاكتئاب، والنمط الزمني، والوظیفیة الدماغیة. وقد 
(، والنمط GEEالدماغیة في تخطیط كھربیة الدماغ )اختصاًرا  العصبي السیروتونیني، والتذبذبات
الزمني، والتعبیر عن أعراض الاكتئاب عند الأشخاص الأصحاء. بالتحدید، فحصنا اثنین من التعددات 
 34
 
)اختصاًرا  A1الشكلیة التي تحدث بصورة طبیعیة في جین مستقبلة السیروتونین من النمط 
ن غیر مباشرین للنقل العصبي السیروتونیني ولعمل یمقیاسباعتبارھما ، 2REP(، وجین A1TH5
 الساعة الیوماویة، على الترتیب.
فحصنا ثلاثة وستین شخًصا، وأخضعناھم لتقییم لطور الساعة البیولوجیة لدیھم )نمطھم الزمني(، 
وفحصنا أعراض الاكتئاب السریري لدیھم. كما فحصنا مجموعة جزئیة من الأشخاص باستخدام 
كھربیة الدماغ من أجل فحص نشاط دماغھم الأساسي واستجابتھم لمختلف المحفزات. فحصنا تخطیط 
 .2REPو A1TH5 لجینَْین النمط الجیني لأغلب الأشخاص، وذلك للنمطین الشكلیین ل
أكدت نتائجنا وجود علاقة تبادلیة بین ھذه العوامل الأربعة. وبالتحدید، وجدنا أن الأشخاص الذین 
زمني متأخر یظھرون نسبة أعلى من أعراض الاكتئاب، ووجدنا أن قوة موجات ثیتا  یتمیزون بنمط
كانت مرتبطة بشكل إیجابي بالنمط الزمني. كما وجدنا دلیًلا غیر مباشر على علاقة النمط الجیني 
 بالنمط الزمني، ولكنا لم نحصل على علاقة مباشرة تؤكد ھذه النتیجة.
ئیة للعلاقة بین وظیفیة الساعة البیولوجیة مع یة على الأسس الجزنا ھذه الدراسة بأدلة مبدئیدتزو
السیروتونین على أنھما آلیتان مقترحتان لحدوث الاكتئاب السریري. یجب أن تشتمل الدراسات 
المستقبلیة على عینات بحجم أكبر وعلى أشخاص مصابین بالاكتئاب السریري من أجل العثور على 
مة والحالات المرضیة، وھذا سیساعد في تكوین صورة أكثر شموًلا فرق واضح بین الحالات السلی
للفیزیولوجیا المرضیة الكامنة وراء الاكتئاب. وفي النھایة، یمكن لذلك أن یرفد عملیات تطویر 
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